Drug Development
Phase I reverse cholesterol transport trial initiated
Published in Medical Letter on the CDC and FDA, February 5th, 2006
The allowance of the investigational new drug application (IND) by the U.S. Food and Drug Administration (FDA) triggers a $5 million milestone payment from AstraZeneca to Avanir, the first designated milestone under the terms of the research collaboration and license agreement entered into in July 2005.
"We are pleased that we successfully submitted the U.S. IND for AZD2479 in a timely way. The FDA's allowance of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Enterobacter Diagnosis
Method is developed to differentiate thermal-resistant strains of Enterobacter sakazakii - Mutagenicity
In silico screening of chemicals for bacterial mutagenicity has been developed - Preterm Birth
Review examines genetic variation associated with preterm birth - Tuberculosis Therapy
Point mutations in M. tuberculosis genes linked to drug resistance are identified - Water-Borne Illness
Home-based water chlorination reduces diarrhea in HIV-infected Ugandans - Adverse Events
Study refutes link between suicide risk, antidepressants - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
